Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Myriad Genetics (MYGN) over the last 17 years, with Q3 2025 value amounting to $145.4 million.

  • Myriad Genetics' Cash & Current Investments rose 4554.55% to $145.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $145.4 million, marking a year-over-year increase of 4554.55%. This contributed to the annual value of $102.4 million for FY2024, which is 2732.43% down from last year.
  • Myriad Genetics' Cash & Current Investments amounted to $145.4 million in Q3 2025, which was up 4554.55% from $74.4 million recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Cash & Current Investments registered a high of $366.1 million during Q3 2021, and its lowest value of $74.4 million during Q2 2025.
  • For the 5-year period, Myriad Genetics' Cash & Current Investments averaged around $156.1 million, with its median value being $121.6 million (2023).
  • As far as peak fluctuations go, Myriad Genetics' Cash & Current Investments soared by 12824.19% in 2021, and later crashed by 7056.84% in 2023.
  • Over the past 5 years, Myriad Genetics' Cash & Current Investments (Quarter) stood at $338.8 million in 2021, then tumbled by 66.09% to $114.9 million in 2022, then increased by 22.63% to $140.9 million in 2023, then fell by 27.32% to $102.4 million in 2024, then surged by 41.99% to $145.4 million in 2025.
  • Its Cash & Current Investments stands at $145.4 million for Q3 2025, versus $74.4 million for Q2 2025 and $91.8 million for Q1 2025.